All Stories

  1. Bridging the operational gap in population pharmacokinetic-pharmacodynamic analysis: an international perspective on the 2025 Chinese group standard

    Article • Journal of Pharmacokinetics and Pharmacodynamics, July 2026, Springer Science + Business Media

    Zheng Jiao

  2. Population Pharmacokinetics and Exposure–Response Analysis of Oral Pixavir Marboxil in Adults and Adolescents with Influenza

    Article • Pharmaceutics, April 2026, MDPI AG

    Zheng Jiao

  3. Bayesian-Based Pharmacokinetic Framework Integrated with Therapeutic Drug Monitoring for Assessing Adherence to Antiseizure Medications: A Clinical Trial Simulation Study

    Article • Journal of Medical Internet Research, January 2026, JMIR Publications Inc.

    Zheng Jiao

  4. Model-informed precision pyrazinamide dosing: The establishment of a population pharmacokinetic model repository for clinical decision support

    Article • International Journal of Antimicrobial Agents, January 2026, Elsevier

    Zheng Jiao

  5. Pharmacokinetic interactions of fruit juices with antihypertensive drugs in humans: A systematic review and meta-analysis

    Article • Complementary Therapies in Medicine, June 2025, Elsevier

    Zheng Jiao

  6. Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics

    Article • Annals of Medicine, May 2025, Taylor & Francis

    Zheng Jiao

  7. Once‐ Versus Twice‐Daily Tacrolimus Therapy: Does Improved Adherence Lead to Better Efficacy?—A Pharmacokinetic Perspective

    Article • The Journal of Clinical Pharmacology, March 2025, Wiley

    Zheng Jiao

  8. Corrigendum to “External evaluation of tacrolimus population pharmacokinetic models in adult lung transplant patients: How to enhance the predictive ability of the model?” [Int. Immunopharmacol. 143 (2024) 113225]

    Article • International Immunopharmacology, January 2025, Elsevier

    Zheng Jiao

  9. A tumor-conditional IL-15 safely synergizes with immunotherapy to enhance antitumor immune responses

    Article • Molecular Therapy, December 2024, Elsevier

    Zheng Jiao

  10. External evaluation of tacrolimus population pharmacokinetic models in adult lung transplant patients: How to enhance the predictive ability of the model?

    Article • International Immunopharmacology, December 2024, Elsevier

    Zheng Jiao

  11. Handling delayed or missed direct oral anticoagulant doses: model-informed individual remedial dosing

    Article • Blood Advances, November 2024, American Society of Hematology

    Zheng Jiao

  12. A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models

    Article • European Journal of Pharmaceutics and Biopharmaceutics, November 2024, Elsevier

    Zheng Jiao

  13. Do Chinese HIV-infected adult patients with altered renal function need to adjust tenofovir disoproxil fumarate dosage? A population pharmacokinetics analysis

    Article • European Journal of Pharmaceutical Sciences, October 2024, Elsevier

    Zheng Jiao

  14. Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients

    Article • Pharmaceutics, August 2024, MDPI AG

    Zheng Jiao

  15. Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants

    Article • Expert Opinion on Drug Metabolism & Toxicology, August 2024, Taylor & Francis

    Zheng Jiao

  16. Toward Model-Informed Precision Dosing for Remimazolam: A Population Pharmacokinetic–Pharmacodynamic Analysis

    Article • Pharmaceutics, August 2024, MDPI AG

    Zheng Jiao

  17. Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients

    Article • July 2024, MDPI AG

    Zheng Jiao

  18. Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis

    Article • Acta Pharmacologica Sinica, May 2024, Springer Science + Business Media

    Zheng Jiao

  19. Corrigendum to “External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients” [Journal of Global Antimicrobial Resistance 35 (2023) 347-353]

    Article • Journal of Global Antimicrobial Resistance, March 2024, Elsevier

    Zheng Jiao

  20. Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer

    Article • Pharmaceuticals, February 2024, MDPI AG

    Zheng Jiao

  21. Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID‐19

    Article • Fundamental and Clinical Pharmacology, February 2024, Wiley

    Zheng Jiao

  22. Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis: A phase IV, 24-week multicenter study

    Article • Chinese Medical Journal, February 2024, Wolters Kluwer Health

    Zheng Jiao

  23. Effect of Voriconazole on Tacrolimus Blood Concentration in Renal Transplant Recipients after Voriconazole Discontinuation

    Article • Journal of Clinical Pharmacy and Therapeutics, January 2024, Wiley

    Zheng Jiao

  24. Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review

    Article • Expert Review of Clinical Pharmacology, December 2023, Taylor & Francis

    Zheng Jiao

  25. External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients

    Article • Journal of Global Antimicrobial Resistance, December 2023, Elsevier

    Zheng Jiao

  26. Factors influencing methotrexate pharmacokinetics highlight the need for individualized dose adjustment: a systematic review

    Article • European Journal of Clinical Pharmacology, November 2023, Springer Science + Business Media

    Zheng Jiao

  27. Quantitative risk-benefit profiles of oral contraceptives, insulin sensitizers and antiandrogens for women with polycystic ovary syndrome: A model-based meta-analysis

    Article • European Journal of Pharmaceutical Sciences, November 2023, Elsevier

    Zheng Jiao

  28. External evaluation and systematic review of population pharmacokinetic models for high-dose methotrexate in cancer patients

    Article • European Journal of Pharmaceutical Sciences, July 2023, Elsevier

    Zheng Jiao

  29. Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice

    Article • Frontiers in Pharmacology, June 2023, Frontiers

    Zheng Jiao

  30. Significant predictors for olanzapine pharmacokinetics: a systematic review of population pharmacokinetic studies

    Article • Expert Review of Clinical Pharmacology, June 2023, Taylor & Francis

    Zheng Jiao

  31. Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics Approach

    Article • Expert Opinion on Investigational Drugs, May 2023, Taylor & Francis

    Zheng Jiao

  32. Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients during the Early Stages Post-Lung Transplantation

    Article • Journal of Personalized Medicine, April 2023, MDPI AG

    Zheng Jiao

  33. Parametric population pharmacokinetics of isoniazid: a systematic review

    Article • Expert Review of Clinical Pharmacology, April 2023, Taylor & Francis

    Zheng Jiao

  34. Physiologically based pharmacokinetic modeling to predict OAT3-mediated drug-drug interactions of meropenem in varying stages of chronic kidney disease

    Article • European Journal of Pharmaceutical Sciences, April 2023, Elsevier

    Zheng Jiao

  35. Handling Delayed or Missed Dose of Antiseizure Medications

    Article • Neurology, February 2023, Wolters Kluwer Health

    Zheng Jiao

  36. Is a Lower Dose of Rivaroxaban Required for Asians? A Systematic Review of a Population Pharmacokinetics and Pharmacodynamics Analysis of Rivaroxaban

    Article • Pharmaceutics, February 2023, MDPI AG

    Zheng Jiao

  37. Dose Regimen Optimization of PD-L1 Inhibitor and Nab-paclitaxel in Patients with NSCLC: a Quantitative Systems Pharmacology analysis

    Article • December 2022, Springer Science + Business Media

    Zheng Jiao

  38. Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based pharmacokinetic models

    Article • Frontiers in Pharmacology, November 2022, Frontiers

    Zheng Jiao

  39. Population pharmacokinetic modeling of caffeine in preterm infants with apnea of prematurity: New findings from concomitant erythromycin and AHR genetic polymorphisms

    Article • Pharmacological Research, October 2022, Elsevier

    Zheng Jiao

  40. Predicting drug-drug interactions with physiologically based pharmacokinetic/pharmacodynamic modelling and optimal dosing of apixaban and rivaroxaban with dronedarone co-administration

    Article • Thrombosis Research, October 2022, Elsevier

    Zheng Jiao

  41. Pharmacokinetic Evaluation of Tacrolimus in Chinese Adult Patients Receiving Voriconazole During the Early Stage Post-Lung Transplantation

    Article • September 2022, Research Square

    Zheng Jiao

  42. Effect of Meal Timings and Meal Content on the AUC 0‐12h of Mycophenolic Acid: A Simulation Study

    Article • Clinical Pharmacology in Drug Development, August 2022, Wiley

    Zheng Jiao

  43. The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study

    Article • Frontiers in Pharmacology, June 2022, Frontiers

    Zheng Jiao

  44. Parametric population pharmacokinetics of linezolid: A systematic review

    Article • British Journal of Clinical Pharmacology, May 2022, Wiley

    Zheng Jiao

  45. Application of Physiologically Based Pharmacokinetic Modeling in Preclinical Studies: A Feasible Strategy to Practice the Principles of 3Rs

    Article • Frontiers in Pharmacology, May 2022, Frontiers

    Zheng Jiao

  46. Population pharmacokinetics and model-informed precision dosing of lamivudine in Chinese HIV-infected patients with mild and moderate impaired renal function

    Article • Expert Review of Clinical Pharmacology, May 2022, Taylor & Francis

    Zheng Jiao

  47. Application of physiologically-based pharmacokinetic and pharmacodynamics modeling to predict drug-drug interactions of dronedarone as a perpetrator with oral anti-coagulants

    Article • April 2022, Springer Science + Business Media

    Zheng Jiao

  48. Model Informed Development of SIM0295 in Gout Patients with Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/pharmacodynamics Approach

    Article • April 2022, Research Square

    Zheng Jiao

  49. Handling Delayed or Missed Dose of Antiepileptic Drugs: A Model-Informed Individual Remedial Dosing

    Article • April 2022, Research Square

    Zheng Jiao

  50. How to handle a delayed or missed dose of edoxaban in patients with non‐valvular atrial fibrillation? A model‐informed remedial strategy

    Article • British Journal of Clinical Pharmacology, April 2022, Wiley

    Zheng Jiao

  51. Interactions Between Meropenem and Renal Drug Transporters

    Article • Current Drug Metabolism, April 2022, Bentham Science Publishers

    Zheng Jiao

  52. Population Pharmacokinetics of Oxcarbazepine: A Systematic Review

    Article • March 2022, Authorea, Inc.

    Zheng Jiao

  53. Population pharmacokinetic and pharmacodynamic analysis of rivaroxaban in Chinese patients with non-valvular atrial fibrillation

    Article • Acta Pharmacologica Sinica, March 2022, Springer Science + Business Media

    Zheng Jiao

  54. Population Pharmacokinetics of Linezolid: A Systematic Review

    Article • February 2022, Authorea, Inc.

    Zheng Jiao

  55. Precision Cardio-Oncology: Use of Mechanistic Pharmacokinetic and Pharmacodynamic Modeling to Predict Cardiotoxicities of Anti-Cancer Drugs

    Article • Frontiers in Oncology, January 2022, Frontiers

    Zheng Jiao

  56. How to handle the delayed or the missed dose of edoxaban in patients with non-valvular atrial fibrillation: model-informed remedial strategy

    Article • November 2021, Wiley

    Zheng Jiao

  57. Model Based Identification of Linezolid Exposure–toxicity Thresholds in Hospitalized Patients

    Article • Frontiers in Pharmacology, October 2021, Frontiers

    Zheng Jiao

  58. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome

    Article • International Immunopharmacology, September 2021, Elsevier

    Zheng Jiao

  59. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis

    Article • Pharmacogenomics and Personalized Medicine, September 2021, Taylor & Francis

    Zheng Jiao

  60. How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing

    Article • Expert Review of Clinical Pharmacology, July 2021, Taylor & Francis

    Zheng Jiao

  61. Genetic polymorphisms in metabolic enzymes and transporters have no impact on mycophenolic acid pharmacokinetics in adult kidney transplant patients co‐treated with tacrolimus: A population analysis

    Article • Journal of Clinical Pharmacy and Therapeutics, July 2021, Wiley

    Zheng Jiao

  62. Population pharmacokinetics of oxcarbazepine: a systematic review

    Article • Expert Review of Clinical Pharmacology, July 2021, Taylor & Francis

    Zheng Jiao

  63. Role of organic anion transporter 3 in the renal excretion of biapenem and potential drug-drug interactions

    Article • European Journal of Pharmaceutical Sciences, July 2021, Elsevier

    Zheng Jiao

  64. Caspofungin pharmacokinetics and probability of target attainment in ICU patients in China

    Article • Journal of Global Antimicrobial Resistance, June 2021, Elsevier

    Zheng Jiao

  65. Population Pharmacokinetics of Ropeginterferon Alfa-2b: A Comparison Between Healthy Caucasian and Chinese Subjects

    Article • Frontiers in Pharmacology, May 2021, Frontiers

    Zheng Jiao

  66. Establishment of a population pharmacokinetics model of vancomycin in 94 infants with septicemia and its application in individualized therapy

    Article • BMC Pharmacology and Toxicology, May 2021, Springer Science + Business Media

    Zheng Jiao

  67. Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer

    Article • European Journal of Pharmaceutical Sciences, April 2021, Elsevier

    Zheng Jiao

  68. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co‐administration with Wuzhi capsule in Chinese renal transplant recipients

    Article • Journal of Clinical Pharmacy and Therapeutics, March 2021, Wiley

    Zheng Jiao

  69. External Evaluation of Vancomycin Population Pharmacokinetic Models at Two Clinical Centers

    Article • Frontiers in Pharmacology, March 2021, Frontiers

    Zheng Jiao

  70. External evaluation of the predictive performance of seven population pharmacokinetic models for phenobarbital in neonates

    Article • British Journal of Clinical Pharmacology, March 2021, Wiley

    Zheng Jiao

  71. Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing

    Article • International Journal of Antimicrobial Agents, March 2021, Elsevier

    Zheng Jiao

  72. Population Pharmacokinetics of Oxcarbazepine: A Systematic Review

    Article • January 2021, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  73. Population Pharmacokinetics of Levetiracetam: A Systematic Review

    Article • Clinical Pharmacokinetics, January 2021, Springer Science + Business Media

    Zheng Jiao

  74. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model

    Article • European Journal of Clinical Pharmacology, January 2021, Springer Science + Business Media

    Zheng Jiao

  75. Investigating the interaction between nifedipine‐ and ritonavir‐containing antiviral regimens: a physiologically‐based pharmacokinetic/pharmacodynamic analysis

    Article • British Journal of Clinical Pharmacology, December 2020, Wiley

    Zheng Jiao

  76. Population pharmacokinetics of azathioprine active metabolite in patients with inflammatory bowel disease and dosage regimens optimisation

    Article • Basic & Clinical Pharmacology & Toxicology, November 2020, Wiley

    Zheng Jiao

  77. Evidence-based Guideline for Therapeutic Drug Monitoring of Vancomycin: 2020 Update by the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    Article • Clinical Infectious Diseases, November 2020, Oxford University Press (OUP)

    Zheng Jiao, Wei Zhao

  78. Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy

    Article • Acta Pharmacologica Sinica, November 2020, Springer Science + Business Media

    Zheng Jiao

  79. Population pharmacokinetic and optimization of polymyxin B dosing in adult patients with various renal functions

    Article • British Journal of Clinical Pharmacology, October 2020, Wiley

    Zheng Jiao

  80. Remedial dosing regimens for delayed or missed rivaroxaban doses in patients with non-valvular atrial fibrillation based on Monte Carlo simulation

    Article • October 2020, Wiley

    Zheng Jiao

  81. Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization

    Article • Frontiers in Pharmacology, October 2020, Frontiers

    Zheng Jiao

  82. Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations

    Article • Epilepsy & Behavior, October 2020, Elsevier

    Zheng Jiao

  83. Incorporating nonlinear kinetics to improve predictive performance of population pharmacokinetic models for ciclosporin in adult renal transplant recipients: A comparison of modelling strategies

    Article • European Journal of Pharmaceutical Sciences, October 2020, Elsevier

    Zheng Jiao

  84. Can Population Pharmacokinetics of Antibiotics be Extrapolated? Implications of External Evaluations

    Article • Clinical Pharmacokinetics, September 2020, Springer Science + Business Media

    Zheng Jiao

  85. External validation of the predictive performance of population pharmacokinetic models for phenobarbital in pediatric patients

    Article • September 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  86. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients

    Article • European Journal of Pharmaceutical Sciences, September 2020, Elsevier

    Zheng Jiao

  87. Evaluation of the Impacts of Formulation Parameters on the Pharmacokinetics and Bioequivalence of Risperidone Orodispersible Film: a Physiologically Based Pharmacokinetic Modeling Approach

    Article • AAPS PharmSciTech, August 2020, Springer Science + Business Media

    Zheng Jiao

  88. Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  89. Remedial dosing recommendation for delayed or missed rivaroxaban doses for patients with non-valvular atrial fibrillation based on Monte Carlo simulation

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  90. A Review of Population Pharmacokinetic Studies of Levetiracetam

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  91. TDM-guided medication of polymyxin B in a patient with CRKP-induced bloodstream infection: a case report

    Article • European Journal of Clinical Microbiology & Infectious Diseases, July 2020, Springer Science + Business Media

    Zheng Jiao

  92. Population Pharmacokinetics of an Anti-PD-1 Antibody Camrelizumab in Patients with Multiple tumor types and model informed dosing strategy

    Article • July 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  93. Probable Drug Interaction Between Etanercept and Cyclosporine Resulting in Clinically Unexpected Low Trough Concentrations: First Case Report

    Article • Frontiers in Pharmacology, June 2020, Frontiers

    Zheng Jiao

  94. Investigation on the interaction between nifedipine and ritonavir containing antivirus regimens: a physiologically-based pharmacokinetic/pharmacodynamic analysis

    Article • May 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  95. Population pharmacokinetics of vancomycin in Chinese elderly patients and its application for dose individualisation

    Article • Journal of Chinese Pharmaceutical Sciences, April 2020, Journal of Chinese Pharmaceutical Sciences

    Zheng Jiao

  96. Pharmacokinetics and pharmacogenetics of high-dose methotrexate in Chinese adult patients with non-Hodgkin lymphoma: a population analysis

    Article • Cancer Chemotherapy and Pharmacology, April 2020, Springer Science + Business Media

    Zheng Jiao

  97. Determination of vancomycin exposure target and individualized dosing recommendations for ICU neonates: model informed precision dosing

    Article • April 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  98. Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients

    Article • Frontiers in Pharmacology, March 2020, Frontiers

    Zheng Jiao

  99. Population Pharmacokinetic Analysis of Tacrolimus in Adult Chinese Patients with Myasthenia Gravis: A Prospective Study

    Article • European Journal of Drug Metabolism and Pharmacokinetics, March 2020, Springer Science + Business Media

    Zheng Jiao

  100. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients

    Article • European Journal of Pharmaceutical Sciences, March 2020, Elsevier

    Zheng Jiao

  101. Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson's Disease Patients With Renal Impairment

    Article • The Journal of Clinical Pharmacology, February 2020, Wiley

    Zheng Jiao

  102. Physiologically Based Pharmacokinetic Modeling to Understand the Absorption of Risperidone Orodispersible Film

    Article • Frontiers in Pharmacology, February 2020, Frontiers

    Zheng Jiao

  103. Incorporating Nonlinear Kinetics to Improve the Predictive Performance of Population Pharmacokinetic Models for Ciclosporin in Adult Renal Transplant Recipients: A Comparison of Modelling Strategies

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  104. A reappraisal of polymyxin B dosing based on population pharmacokinetic model in patient with renal insufficiency

    Article • January 2020, Cold Spring Harbor Laboratory Press

    Zheng Jiao

  105. How to Handle Delayed or Missed Doses: A Population Pharmacokinetic Perspective

    Article • European Journal of Drug Metabolism and Pharmacokinetics, December 2019, Springer Science + Business Media

    Zheng Jiao

  106. Population Pharmacokinetic Study of Tacrolimus in Pediatric Patients with Primary Nephrotic Syndrome: A Comparison of Linear and Nonlinear Michaelis–Menten Pharmacokinetic Model

    Article • European Journal of Pharmaceutical Sciences, December 2019, Elsevier

    Zheng Jiao

  107. Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling

    Article • Biomedicine & Pharmacotherapy, November 2019, Elsevier

    Zheng Jiao

  108. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis

    Article • Therapeutic Drug Monitoring, October 2019, Wolters Kluwer Health

    Zheng Jiao

  109. Clinical Evaluation of the Tolerability and Pharmacokinetics of Azilsartan, a Potent Angiotensin Receptor Blocker, in Healthy Chinese Subjects

    Article • Clinical Pharmacology in Drug Development, September 2019, Wiley

    Zheng Jiao

  110. Myasthenia gravis and specific immunotherapy: monoclonal antibodies

    Article • Annals of the New York Academy of Sciences, August 2019, Wiley

    Zheng Jiao

  111. Prediction of Ticagrelor and its Active Metabolite in Liver Cirrhosis Populations Using a Physiologically Based Pharmacokinetic Model Involving Pharmacodynamics

    Article • Journal of Pharmaceutical Sciences, August 2019, Elsevier

    Zheng Jiao

  112. Remedial dosing recommendations for delayed or missed doses of lamotrigine in pediatric patients with epilepsy using Monte Carlo simulations

    Article • Epilepsy & Behavior, July 2019, Elsevier

    Zheng Jiao

  113. Clinical Evaluation of the Tolerability, Pharmacokinetics, and Inhibition of Platelet Aggregation of Eptifibatide in Healthy Chinese Subjects

    Article • Clinical Pharmacology in Drug Development, June 2019, Wiley

    Zheng Jiao

  114. Lower clearance of sodium tanshinone IIA sulfonate in coronary heart disease patients and the effect of total bilirubin: a population pharmacokinetics analysis

    Article • Chinese Journal of Natural Medicines, March 2019, Elsevier

    Zheng Jiao

  115. Population pharmacokinetic and pharmacogenetics of imatinib in Chinese patients with chronic myeloid leukemia

    Article • Pharmacogenomics, March 2019, Future Medicine

    Zheng Jiao

  116. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co‐administered with tacrolimus

    Article • British Journal of Clinical Pharmacology, February 2019, Wiley

    Zheng Jiao

  117. Population pharmacokinetics and dosing regimen optimisation of lopinavir in Chinese adults infected with HIV

    Article • Basic & Clinical Pharmacology & Toxicology, November 2018, Wiley

    Zheng Jiao

  118. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens

    Article • European Journal of Clinical Pharmacology, November 2018, Springer Science + Business Media

    Zheng Jiao

  119. Optimization and application of an HPLC method for quantification of inosine-5′-monophosphate dehydrogenase activity as a pharmacodynamic biomarker of mycophenolic acid in Chinese renal transplant patients

    Article • Clinica Chimica Acta, October 2018, Elsevier

    Zheng Jiao

  120. Pharmacokinetics Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium and Tacrolimus

    Article • Therapeutic Drug Monitoring, October 2018, Wolters Kluwer Health

    Zheng Jiao

  121. FKBP1A rs6041749 polymorphism is associated with allograft function in renal transplant patients

    Article • European Journal of Clinical Pharmacology, September 2018, Springer Science + Business Media

    Zheng Jiao

  122. Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations

    Article • Frontiers in Pharmacology, June 2018, Frontiers

    Zheng Jiao

  123. FOXP3 rs3761549 polymorphism predicts long-term renal allograft function in patients receiving cyclosporine-based immunosuppressive regimen

    Article • Gene, February 2018, Elsevier

    Zheng Jiao

  124. A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption

    Article • BMC Pharmacology and Toxicology, January 2018, Springer Science + Business Media

    Zheng Jiao

  125. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients

    Article • British Journal of Clinical Pharmacology, November 2017, Wiley

    Zheng Jiao

  126. Prediction of Drug-Drug Interaction between Tacrolimus and Principal Ingredients of Wuzhi Capsule in Chinese Healthy Volunteers Using Physiologically-Based Pharmacokinetic Modelling

    Article • Basic & Clinical Pharmacology & Toxicology, October 2017, Wiley

    Zheng Jiao

  127. NFATC1genotypes affect acute rejection and long-term graft function in cyclosporine-treated renal transplant recipients

    Article • Pharmacogenomics, March 2017, Future Medicine

    Zheng Jiao

  128. Chemical profiling of San-Huang decoction by UPLC–ESI-Q-TOF-MS

    Article • Journal of Pharmaceutical and Biomedical Analysis, November 2016, Elsevier

    Zheng Jiao

  129. FOXP3 rs3761548 polymorphism is associated with tacrolimus-induced acute nephrotoxicity in renal transplant patients

    Article • European Journal of Clinical Pharmacology, October 2016, Springer Science + Business Media

    Zheng Jiao

  130. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients

    Article • British Journal of Clinical Pharmacology, February 2016, Wiley

    Zheng Jiao

  131. Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics

    Article • Frontiers in Pharmacology, November 2015, Frontiers

    Zheng Jiao

  132. Effect of long-term coadministration of compound glycyrrhizin tablets on the pharmacokinetics of mycophenolic acid in rats

    Article • Xenobiotica, November 2015, Taylor & Francis

    Zheng Jiao

  133. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens

    Article • European Journal of Clinical Pharmacology, October 2015, Springer Science + Business Media

    Zheng Jiao

  134. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy

    Article • Pharmacogenomics, August 2015, Future Medicine

    Zheng Jiao

  135. SCN1A, ABCC2 and UGT2B7 gene polymorphisms in association with individualized oxcarbazepine therapy

    Article • Pharmacogenomics, March 2015, Future Medicine

    Zheng Jiao

  136. Population Pharmacokinetics of Valproic Acid in Adult Chinese Epileptic Patients and its Application in an Individualized Dosage Regimen

    Article • Therapeutic Drug Monitoring, February 2015, Wolters Kluwer Health

    Zheng Jiao

  137. Vincristine drug safety administration survey: results from hospitals in Shanghai, China

    Article • European Journal of Hospital Pharmacy, January 2015, BMJ

    Zheng Jiao

  138. Application of modeling and simulation techniques in research on medication compliance

    Article • Pharmaceutical Care and Research, December 2014, Publishing House of Pharmaceutical Care and Research

    Zheng Jiao

  139. A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation

    Article • Clinical Pharmacokinetics, November 2014, Springer Science + Business Media

    Zheng Jiao

  140. Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil

    Article • European Journal of Clinical Pharmacology, October 2014, Springer Science + Business Media

    Zheng Jiao

  141. The effects of medication education and behavioral intervention on Chinese patients with epilepsy

    Article • Epilepsy & Behavior, August 2014, Elsevier

    Zheng Jiao

  142. Association of SCN1A , SCN2A and ABCC2 Gene Polymorphisms with the Response to Antiepileptic Drugs in Chinese Han Patients with Epilepsy

    Article • Pharmacogenomics, July 2014, Taylor & Francis

    Zheng Jiao

  143. Validation of Chinese version of the Morisky Medication Adherence Scale in patients with epilepsy

    Article • Seizure, April 2014, Elsevier

    Zheng Jiao

  144. Pharmacokinetic comparisons of berberine and palmatine in normal and metabolic syndrome rats

    Article • Journal of Ethnopharmacology, January 2014, Elsevier

    Zheng Jiao

  145. Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury

    Article • PLOS One, June 2013, PLOS

    Zheng Jiao

  146. Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China

    Article • Epilepsy & Behavior, April 2013, Elsevier

    Zheng Jiao

  147. The effect of poor compliance on the pharmacokinetics of carbamazepine and its epoxide metabolite using Monte Carlo simulation

    Article • Acta Pharmacologica Sinica, October 2012, Springer Science + Business Media

    Zheng Jiao

  148. Genetic association of FOXP3 gene polymorphisms with allograft rejection in renal transplant patients

    Article • Nephrology, April 2012, Wiley

    Zheng Jiao

  149. The Impact of Sulfonylureas on Tacrolimus Apparent Clearance Revealed by a Population Pharmacokinetics Analysis in Chinese Adult Liver-Transplant Patients

    Article • Therapeutic Drug Monitoring, April 2012, Wolters Kluwer Health

    Zheng Jiao

  150. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals

    Article • Clinica Chimica Acta, April 2012, Elsevier

    Zheng Jiao

  151. The Pharmacokinetics of Ropivacaine in Elderly Patients Undergoing Nerve Stimulator–Guided Thoracic Paravertebral Block

    Article • Journal of Cardiothoracic and Vascular Anesthesia, June 2011, Elsevier

    Zheng Jiao

  152. Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis

    Article • Journal of Clinical Pharmacy and Therapeutics, October 2010, Wiley

    Zheng Jiao

  153. Simultaneous determination of procaine, lidocaine, ropivacaine, tetracaine and bupivacaine in human plasma by high-performance liquid chromatography

    Article • Journal of Chromatography B, May 2010, Elsevier

    Zheng Jiao

  154. Simple and Sensitive Determination of Metformin in Human Plasma Using an Ion-Pair LC Method

    Article • Chromatographia, October 2009, Springer Science + Business Media

    Zheng Jiao

  155. Population pharmacokinetics of sirolimus inde novoChinese adult renal transplant patients

    Article • British Journal of Clinical Pharmacology, July 2009, Wiley

    Zheng Jiao

  156. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

    Article • European Journal of Clinical Pharmacology, July 2008, Springer Science + Business Media

    Zheng Jiao

  157. Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9

    Article • British Journal of Clinical Pharmacology, June 2008, Wiley

    Zheng Jiao

  158. Simultaneous determination of aciclovir, ganciclovir, and penciclovir in human plasma by high-performance liquid chromatography with fluorescence detection

    Article • Journal of Chromatography B, May 2008, Elsevier

    Zheng Jiao

  159. Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of their Active Metabolites in Human Plasma

    Article • Chromatographia, January 2007, Springer Science + Business Media

    Zheng Jiao

  160. Quantification of Teicoplanin in Human Plasma by Liquid Chromatography with Ultraviolet Detection

    Article • Chromatographia, November 2006, Springer Science + Business Media

    Zheng Jiao

  161. Clinical Trial Simulation

    Article • November 2006, Taylor & Francis

    Zheng Jiao

  162. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies

    Article • European Journal of Clinical Pharmacology, November 2006, Springer Science + Business Media

    Zheng Jiao

  163. Simultaneous determination of mycophenolic acid and valproic acid based on derivatization by high-performance liquid chromatography with fluorescence detection

    Article • Biomedical Chromatography, January 2006, Wiley

    Zheng Jiao

  164. Errata

    Article • Chromatographia, November 2005, Springer Science + Business Media

    Zheng Jiao

  165. Simple High-Performance Liquid Chromatographic Assay, with Post-Column Derivatization, for Simultaneous Determination of Mycophenolic Acid and its Glucuronide Metabolite in Human Plasma and Urine

    Article • Chromatographia, October 2005, Springer Science + Business Media

    Zheng Jiao

  166. Quantification of total and free mycophenolic acid in human plasma by liquid chromatography with fluorescence detection

    Article • Journal of Chromatography B, March 2005, Elsevier

    Zheng Jiao

  167. The Validation of an LC-MS Method for the Determination of Risperidone and its Active Metabolite 9-Hydroxyrisperidone in Human Plasma

    Article • Chromatographia, March 2005, Springer Science + Business Media

    Zheng Jiao

  168. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data

    Article • Journal of Clinical Pharmacy and Therapeutics, June 2004, Wiley

    Zheng Jiao

  169. Population Pharmacokinetics of Carbamazepine in Chinese Epilepsy Patients

    Article • Therapeutic Drug Monitoring, June 2003, Wolters Kluwer Health

    Zheng Jiao